Related references
Note: Only part of the references are listed.Diazepinone HBV capsid assembly modulators
Scott D. Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Identification of a new class of HBV capsid assembly modulator
Scott D. Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Oxadiazepinone HBV capsid assembly modulators
Scott D. Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection
Chunkyu Ko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators
Scott D. Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus
Jan Martin Berke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
New therapeutic agents for chronic hepatitis B
Mayur Brahmania et al.
LANCET INFECTIOUS DISEASES (2016)
Current treatments for chronic hepatitis B virus infections
Fabien Zoulim et al.
CURRENT OPINION IN VIROLOGY (2016)
Core protein: A pleiotropic keystone in the HBV lifecycle
Adam Zlotnick et al.
ANTIVIRAL RESEARCH (2015)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Mortality due to viral hepatitis in the Global Burden of Disease Study 2010: new evidence of an urgent global public health priority demanding action
Benjamin C. Cowie et al.
ANTIVIRAL THERAPY (2013)
In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations
Xue-Yan Wang et al.
ANTIVIRAL THERAPY (2012)
HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state
Yan-Hai Guo et al.
EPIGENETICS (2011)
Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice
Nicolas Brezillon et al.
PLOS ONE (2011)
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
K Deres et al.
SCIENCE (2003)
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model
O Weber et al.
ANTIVIRAL RESEARCH (2002)
Share Paper
